ATEN THERAPEUTICS
Their management team has extensive experience within the biopharmaceutical industry, and a wealth of knowledge in building successful biotechnology companies. They are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.
ATEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.atentherapeutics.com
Status:
Active
Contact:
+44 [0] 207 493 4546
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF Google Maps Content Delivery Network SSL By Default Font Awesome JsDelivr Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Cardium Therapeutics
Cardium Therapeutics is a regenerative medicine biotechnology company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Lemax
Lemax is a small and innovative medical technology company.
Mitologics
Mitologics is an innovative biotechnology company.
Pentraxin Therapeutics
Pentraxin Therapeutics is a University College London spin out company founded in 2001
Recircle
Rubber recycling and industrial biotechnology company
ReGen Therapeutics
ReGen Therapeutics is a biotech company.
Siragen Pharmaceuticals
Siragen Pharmaceuticals is an innovative biotechnology company.
Syndya Therapeutics
Syndya Therapeutics is a 3D combinatorial, phenotypic screening company.
Investors List
Innovate UK
Innovate UK investment in Grant - Aten Therapeutics
Official Site Inspections
http://www.atentherapeutics.com
- Host name: 206.129.153.160.host.secureserver.net
- IP address: 160.153.129.206
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Aten Therapeutics"
aTen Therapeutics An innovative biotechnology company
August 2022. August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment. March 2020. aTen Therapeutics relocates to new offices at 1 Lochrin Square, Fountainbridge, Edinburgh EH3 …See details»
Aten Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +44 [0] 207 493 4546 Their management team has extensive experience within the …See details»
aTen Therapeutics Ltd - LinkedIn
ATen Therapeutics Ltd Biotechnology EDINBURGH, MIDLOTHIAN 494 followers Pre-clinical Scottish biotech, developing novel antibodies for treating major diseasesSee details»
Overview of aTen Therapeutics leadership team
Overview. aTen Therapeutics Ltd is a pre-clinical stage biotechnology company founded by Professor Christopher Wood, winner of the Lifetime Achievement Award at Scotland’s Annual Life Sciences Awards 2022.See details»
ATEN THERAPEUTICS LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ATEN THERAPEUTICS LTD of EDINBURGH. Get the latest business insights from Dun & Bradstreet.See details»
aTen Therapeutics Profile and History - Datanyze
ATen Therapeutics Ltd (www.atentherapeutics.com) is an innovative Scottish biotechnology company developing novel therapeutic antibody approaches to target a fundamental control …See details»
ATEN THERAPEUTICS LTD - Companies House
ATEN THERAPEUTICS LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Aten Therapeutics - Craft
Aten Therapeutics is a biotechnological company. It develops therapeutic antibody approaches. The company's product Tensinomab can be used to treat cancer and protect from developing …See details»
aTen Therapeutics - Company Profile - Tracxn
Jan 17, 2025 aTen Therapeutics is a Scottish, clinical-stage biotech developing humanized mAbs modulating AT1 Receptors for primary cancers. It is a subsidiary of OncoBioPharm Ltd. …See details»
aTen Therapeutics - VentureRadar
IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be safer than and additive to other anti-fibrotic therapeutic …See details»
aTen Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials
Explore aTen Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:Tensinumab.See details»
OncoBioPharm rebrands as 'aTen Therapeutics'
Feb 1, 2017 Scottish biotechnology company OncoBioPharm has announced that from today it will operate as aTen Therapeutics Ltd. aTen (pronounced ‘atten’) refers to the angiotensin …See details»
aTen Therapeutics's lead candidate Tensinomab
August 2022. August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment. March 2020. aTen Therapeutics relocates to new offices at 1 Lochrin …See details»
Aten Therapeutics - Company Information, Competitors, News
Find useful insights on Aten Therapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Aten Therapeutics.See details»
aTen Therapeutics - PitchBook
ATen Therapeutics General Information Description. Developer of novel therapeutic antibodies designed to offer treatment for major diseases. The company's antibodies block cancer cell …See details»
Nextsource | Company Profile | Aten Therapeutics
Website: atentherapeutics.com. Phone Number: +44 [0] 207 493 4546. Revenue: $$$$ Company Type: For Profit. Founding Year: 2005. Parent Company: N/A. Number of Subsidiaries: N/A. …See details»
aTen Therapeutics - VentureRadar
Website: http://www.atentherapeutics.com/ aTen Therapeutics’ lead candidate Tensinomab is a humanised single chain variable fragment (scFv) monoclonal antibody.See details»
aTen Therapeutics - Products, Competitors, Financials, Employees ...
ATen Therapeutics is an innovative biotechnology company focused on developing novel therapeutic antibodies for the healthcare sector. Use the CB Insights Platform to explore aTen …See details»
aTen Therapeutics to develop new breast cancer treatment
Aug 30, 2022 Scottish Lifesciences Association, 44 Charlotte Square, Edinburgh, EH2 4HQ, Scotland Registered in Scotland - SC390602. Tel: +44 (0) 7753 312 263See details»
Aten Biotherapeutics - VentureRadar
"Aten Biotherapeutics is an innovation driven R&D company focused on the development of affordable and safe healthcare solutions based on bionanotechnoloy.See details»